Log in

MCAG Mountain Crest Acquisition Corp. V OTC · United States

Mountain Crest Acquisition Corp. V (MCAG) news

Mountain Crest Acquisition Corp. V is a public biotech or pharmaceutical company listed on OTC under the ticker MCAG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Mountain Crest Acquisition Corp. V news

We have not published a story on Mountain Crest Acquisition Corp. V yet. When there is news, it will appear here.

Mountain Crest Acquisition Corp. V annual financials

LineFY2025FY2024
Net income (loss)-$431,161-$374,454
Cash from operations-$741,998-$921,200
Cash and equivalents$11,909$116,658

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $18,299.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Mountain Crest Acquisition Corp. V

What is the ticker symbol of Mountain Crest Acquisition Corp. V?

Mountain Crest Acquisition Corp. V trades under the ticker MCAG on OTC.

Where is Mountain Crest Acquisition Corp. V listed?

Mountain Crest Acquisition Corp. V is listed on OTC.

Which country or territory is Mountain Crest Acquisition Corp. V listed under?

Our directory records Mountain Crest Acquisition Corp. V under United States.

Does aibio.space cover Mountain Crest Acquisition Corp. V?

aibio.space lists Mountain Crest Acquisition Corp. V among 2,820 public biotech companies and publishes its news here as stories appear.

Is Mountain Crest Acquisition Corp. V profitable?

Mountain Crest Acquisition Corp. V reported a net loss of $431,161 for the fiscal year ended Dec 31, 2025, and used $741,998 of cash in operations, per its annual report to the SEC.

How much cash does Mountain Crest Acquisition Corp. V have?

$18,299 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Mountain Crest Acquisition Corp. V

Members talk about Mountain Crest Acquisition Corp. V (MCAG). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Mountain Crest Acquisition Corp. V, newest first. Each line links the filing it comes from.

  1. Mergers

    Filed documents for a merger or acquisition. SEC Form DEFM14A. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:MCAG on TradingView.

Listing details

Mountain Crest Acquisition Corp. V is a public biotech or pharmaceutical company listed on OTC under the ticker MCAG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Mountain Crest Acquisition Corp. V
Ticker
MCAG
Listing
OTC
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.